VARIANTS IN THE HTRA1 AND ARMS2 GENES AND OUTCOME OF ANTI-VEGF TREATMENT IN NEOVASCULAR AMD

被引：0
|
作者：
Abedi, Farshad [1 ,2 ,3 ]
Wickremasinghe, Sanjeewa [1 ,2 ,3 ]
Richardson, Andrea J. [1 ,2 ,3 ]
Islam, Fakir A. [1 ,2 ,3 ]
Guymer, Robyn H. [2 ,3 ]
Baird, Paul N. [1 ,2 ,3 ]
机构：
[1] Ctr Eye Res Australia, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2012年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] Changes in OCT-Angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment.
    Faatz, Henrik
    Farecki, Marie-Louise
    Heimes, Britta
    Kai, Rothaus
    Lommatzsch, Albrecht
    Pauleikhoff, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [42] Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD
    Boscia, Giacomo
    Bacherini, Daniela
    Vujosevic, Stela
    Grassi, Maria Oliva
    Borrelli, Enrico
    Giancipoli, Ermete
    Landini, Luca
    Pignataro, Mariagrazia
    Alessio, Giovanni
    Boscia, Francesco
    Viggiano, Pasquale
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (10)
  • [43] Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review
    Khanna, Saira
    Komati, Rahul
    Eichenbaum, David A.
    Hariprasad, Ishani
    Ciulla, Thomas A.
    Hariprasad, Seenu M.
    BMJ OPEN OPHTHALMOLOGY, 2019, 4 (01):
  • [44] Defining the risk of adverse cardiovascular events for patients undergoing anti-VEGF treatment for neovascular AMD
    Chong, David Donghan
    Maatouk, Christopher M.
    Singh, Rishi
    Talcott, Katherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [45] Real-World Treatment Patterns in a Population With Neovascular AMD Treated With Anti-VEGF Agents
    Urbano, Catherine A.
    Maatouk, Christopher
    Greenlee, Tyler
    Chen, Andrew
    Conti, Thais F.
    Briskin, Isaac
    Singh, Rishi P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021, 52 (04): : 190 - 198
  • [46] AUDIT ON ANTI-VEGF TREATMENT FOR NEOVASCULAR AMD AT THE ROYAL VICTORIAN EYE AND EAR HOSPITAL (RVEEH)
    Abedi, Farshad
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 73 - 73
  • [47] Treatment Burden in Neovascular AMD: Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency
    Hussain, Rehan M.
    Hariprasad, Seenu M.
    Ciulla, Thomas A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (10): : 780 - 784
  • [48] Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration
    Pan, Yang
    Fu, Yingbin
    Baird, Paul N.
    Guymer, Robyn H.
    Das, Taraprasad
    Iwata, Takeshi
    PROGRESS IN RETINAL AND EYE RESEARCH, 2023, 97
  • [49] Gene Structure of the 10q26 Locus: A Clue to Cracking the ARMS2/HTRA1 Riddle?
    Kortvely, Elod
    Ueffing, Marius
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2016, 854 : 23 - 29
  • [50] Recombinant Haplotypes Narrow the ARMS2/HTRA1 Association Signal for Age-Related Macular Degeneration
    Grassmann, Felix
    Heid, Iris M.
    Weber, Bernhard H. F.
    GENETICS, 2017, 205 (02) : 919 - 924
12345